AIDS 2026, the 26th International AIDS Conference

AIDS 2026 will take place in Rio de Janeiro, Brazil, and virtually on 26-31 July 2026.

Join us
Rio de Janeiro, Brazil

We convene, educate and advocate for a world in which HIV no longer presents a threat to public health and individual well-being.

The IAS unites the global HIV response because progress happens when science, policy and activism come together. Here’s how we do this:

Rio de Janeiro, Brazil

AIDS 2026

The 26th International AIDS Conference

AIDS 2026, the 26th International AIDS Conference, taking place in Rio de Janeiro, Brazil, and virtually on 26-31 July 2026.

View details

Events

26 Jul 2026
AIDS 2026 pre-conference, "Advancing HIV prevention science and access"

To accelerate progress in HIV prevention, it is increasingly important to translate emerging scientific innovations into real-world impact. Recent breakthroughs, including the approval of lenacapavir, the first twice-yearly injectable PrEP, alongside advances in broadly neutralizing antibodies, mRNA-based platforms and immunogen design, are expanding the range of prevention options. However, these advances will have impact only if they are affordable, accessible and delivered at scale, particularly in low- and middle-income settings and for people most affected by HIV.

View details View details
26 Jul 2026
AIDS 2026 HIV cure pre-conference, "HIV cure without borders: Science, community and Latin America and Caribbean perspectives"
The pre-conference will strengthen community and clinical understanding of HIV cure research priorities. View details View details
26 Jul 2026
AIDS 2026 pre-conference: 12th Symposium on Children and Adolescents with Perinatal HIV Exposure

As of 2024, an estimated 16 million children under 15 years of age had been perinatally exposed to HIV globally and were born HIV-free. An expanding body of evidence shows that these children experience a higher likelihood of infectious morbidity, mortality, impaired growth and suboptimal neurodevelopmental and cognitive outcomes than peers born to mothers without HIV, with the aetiology of these adverse outcomes reflecting an interplay of biological, social and structural factors.

View details View details
See us make a difference

Sign up to receive our newsletter. Stay updated on our efforts and impact and learn how to make a difference.

The IAS at a glance

We unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all people living with and affected by HIV. Here are some numbers that show how we do that.

676

IAS change makers. Carefully selected HIV researchers, advocates, healthcare providers and others help us drive an evidence-based HIV response that puts people first.

10,000+

IAS Members worldwide. We convene people from diverse backgrounds to drive a shared vision of a world in which HIV is no longer a threat to public health and individual well-being.

4,219

Scientific studies shared through our conferences and the Journal of the International AIDS Society in 2022/23. We advocate for evidence-based progress to improve the lives of people living with and affected by HIV. 

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.